| |
|
Form Serial Number: |
CS20260921E00286 |
| 1.
Date of relevant event: |
07/09/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02041 |
| 4.
Name of listed corporation: |
Medcaptain Medical Technology Co., Ltd. - H Shares |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
479,221,686 |
| 7.
Name of substantial shareholder: |
Zhuhai Gao Ling Private Fund Management Co., Ltd. |
| 8.
Registered office: |
珠海市横琴环岛东路3018号2223办公 |
| 9.
Principal place of business in Hong Kong: |
Nil |
| 15.
Exchange on which listed: |
Nil |
| 16.
Name of listed parent and exchange on which parent is listed: |
Nil |
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1701 | Miscellaneous
On listing of the corporation or a class of shares of the listed corporation |
|
|
| 2201 | Interest of corporation controlled by you |
|
51,950,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 0 | 0.00 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 51,950,000 | 10.84 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
Zhuhai Gao Ling Tiancheng Equity Investment Fund (Limited Partnership) and Suzhou Gao Ling Qirui Medical Health Industry Investment Partnership Enterprise (Limited Partnership) are managed by the substantial shareholder. Tianjin Zhenying Enterprise Management Consultancy Limited Partnership (Limited Partnership) and Zhuhai Aiheng Equity Investment Partnership (Limited Partnership) are limited partnerships whose limited partners are managed by the substantial shareholder.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
21/09/2026
(dd/mm/yyyy)
|
|
|
|
|